AcouSort AB Market Cap ($7.49 Million)
Market Cap & Net Worth: AcouSort AB (ACOU)
AcouSort AB market cap. AcouSort AB (ST:ACOU) has a market capitalization of $7.49 Million (Skr69.63 Million) as of November 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #27636 globally and #599 in its home market, demonstrating a -0.60% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AcouSort AB's stock price Skr3.29 by its total outstanding shares 21163902 (21.16 Million). Also see cash flow conversion of AcouSort AB for how efficiently the company converts equity into cash flow.
AcouSort AB Market Cap History (2020–2026)
AcouSort AB market cap history from 2020 to 2026. Data shows change from $52.89 Million to $7.49 Million (-26.47% CAGR). Check AcouSort AB stock quote for real-time trading data and today's change.
Index Memberships
AcouSort AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.29 Billion | 0.05% | #168 of 281 |
Weight: AcouSort AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
AcouSort AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AcouSort AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ACOU net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.94x
AcouSort AB's market cap is 0.94 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $52.89 Million | $4.93 Million | -$8.22 Million | 10.73x | N/A |
| 2021 | $58.06 Million | $3.01 Million | -$12.38 Million | 19.31x | N/A |
| 2022 | $33.70 Million | $4.96 Million | -$13.21 Million | 6.79x | N/A |
| 2023 | $35.42 Million | $10.55 Million | -$17.09 Million | 3.36x | N/A |
| 2024 | $25.05 Million | $4.74 Million | -$15.08 Million | 5.29x | N/A |
| 2025 | $6.45 Million | $6.85 Million | -$12.15 Million | 0.94x | N/A |
Competitor Companies of ACOU by Market Capitalization
Companies near AcouSort AB in the global market cap rankings as of November 4, 2026. Also see ACOU current and non-current assets for a full breakdown of the balance sheet.
Key companies related to AcouSort AB by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of AcouSort AB (2020–2026)
Market capitalization of AcouSort AB from 2020 to today. Between 2020 and today, AcouSort AB's market cap moved from $52.89 Million to $ 7.49 Million, with a yearly change of -26.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr7.49 Million | +16.25% |
| 2025 | Skr6.45 Million | -74.27% |
| 2024 | Skr25.05 Million | -29.26% |
| 2023 | Skr35.42 Million | +5.09% |
| 2022 | Skr33.70 Million | -41.95% |
| 2021 | Skr58.06 Million | +9.78% |
| 2020 | Skr52.89 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of AcouSort AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.49 Million USD |
| MoneyControl | $7.49 Million USD |
| MarketWatch | $7.49 Million USD |
| marketcap.company | $7.49 Million USD |
| Reuters | $7.49 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About AcouSort AB
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acous… Read more